“The Key players in the Stem Cell Assays Market include Thermo Fisher Scientific Inc. (US), Merck KGaA (Germany), Danaher (US), Becton, Dickinson and Company (US), Bio-Rad Laboratories (US), Promega ...

In the ever-evolving landscape of biomedical research, the need for reliable, consistent, and ready-to-use cell models has never been more critical. ATCC, a leading provider of biological materials, ...

The Europe stem cell assay market is expected to grow $793 million by 2025. The market growth is expected at the CAGR of 21.49% in the forecast period. The base year considered for the market study is ...

Keeping Cells “Happy” and Healthy Helps Support Complex Multiplexed Assays Maintaining cell viability throughout the cell culture process is virtually a nonissue in current drug discovery efforts. But ...

Axion BioSystems today announced that the FDA's Center for Drug Evaluation and Research (CDER) has accepted the company’s letter of intent (LOI) into the Innovative Science and Technology Approaches ...

Cell culture samples consisting of multiple cells provide only an average response rate to manipulation. Whole cell populations thereby miss unique responses of cell subpopulations. Scientists could ...

New Assay Expands INDIGO’s GPCR Portfolio and Supports Development of Next-Generation CNS-Related Therapeutics STATE ...

This article is based on a poster originally authored by Blaise Louis, Serena Belluschi, Daniel Weekes, Tom Mitchell, Holly Herbert, Tarun Vemulkar and Jeroen Verheyen, which was presented at ELRIG ...

The primary causes of disability and mortality in the US are chronic diseases such as cancer, neurodegenerative disorders, cardiovascular disease, obesity, arthritis, and diabetes. The increase in ...

Stem cells can give rise to differentiated progenies with reduced proliferative potential. As a consequence, the most definitive way to assess putative cancer stem cells is to inject them into animal ...